Here’s what you should know:
1. Plenvu additionally focuses on preparing the ascending colon.
2. If approved, Plenvu will tout the lowest total volume of solution for a bowel cleanser.
3. Salix expects an FDA decision in the first quarter of fiscal year 2018.
4. Salix is a subsidiary of Valeant Pharmaceuticals.
More articles on gastroenterology:
Synthetic Biologics receives Patent office allowance for active agent in IBS-C treatment — 3 key notes
GI center to know: Gastroenterology of the Rockies
Exact Sciences partners with pro-golfer & more — 6 GI company key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
